Secondary Pharmaceutical Drug Supplies for the Walter Reed National Military Medical Center Pharmacy Department
Closed Pre-Solicitation Posted
- Solicitation number
- HT001425QE013
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20889, United States
- Points of contact
-
- Kendall Spann kendall.j.spann.civ@health.mil (703) 275-6344
- Claudia Febres Mormontoy claudia.a.febresmormontoy.ctr@health.mil (703) 275-6342
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency (DHA) National Capital Region is conducting market research on behalf of the Walter Reed National Military Medical Center for the procurement of secondary pharmaceutical drug supplies. This sources sought notice seeks qualified vendors capable of providing various medical pharmaceuticals including Nitroglycerine solutions, Phenylephrine HCL, Potassium Chloride bags, Propofol, Zyprexa, Zoledronic Acid, and multiple injectable and intravenous medications under NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The government intends to award a Firm-Fixed Price Blanket Purchase Agreement for these pharmaceutical supplies as needed by the pharmacy department located at 8901 Wisconsin Avenue Building 54, Bethesda, MD. Interested parties must submit non-proprietary capabilities statements and product lists demonstrating their ability to supply the required pharmaceutical products. The response deadline is Friday, October 10, 2025, at 5:00 PM EDT, with the government considering responses within ten days of the October 1, 2025 posting date. Key points of contact include Kendall Spann (Contracts Specialist) and Faatalivale Te'o-Lewis (Contracting Officer) from the Defense Health Agency.
This opportunity does not include any set-aside designations and is open to all qualified vendors meeting the procurement requirements. No incumbent contractors or current service providers are identified in the notice, nor are any potential award values or budget ranges disclosed at this pre-solicitation stage. The government has not specified quantities for the pharmaceutical supplies, indicating this will likely be an as-needed procurement arrangement typical of Blanket Purchase Agreements. The timeline for actual services or deliveries has not been established, as this sources sought notice is focused on identifying capable suppliers for potential future competition. Phone inquiries will not be accepted, and all responses must be submitted via email to the designated contracting personnel. The government reserves the sole discretion to determine whether to proceed with a competitive procurement based on the market research responses received.
Notice text
This is a sources sought announcement issued by the Defense Health Agency (DHA) National Capital Region (NCR) as part of its market research, on behalf of the Walter Reed National Military Medical Clinic (WRNMMC), 8901 Wisconsin Avenue Building 54 Bethesda, MD 20889, in accordance with FAR Part 13.303, Blanket Purchase Agreements (BPAs) and FAR 16.7, Agreements. The Government intends to award a Firm-Fixed Price, for the procurement of secondary medical pharmaceutical drug supplies as needed.
The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing). The Product Service Codes is 6505 (Drugs and Biologicals).
This announcement is a sources sought. Phone calls will not be accepted. The government will consider responses to this notice within ten (10) days of this posting. Interested parties, may express their interest and provide a capabilities statement products list NLT Friday, 10 October 2025 at 5:00 PM EDT.
A determination by the government not to compete this requirement based upon responses to this notice is solely within the discretion of the government. Information received as a result of this notice will be considered solely for the purpose of determining whether to conduct a competitive procurement.
Interested Parties:
Please submit non-proprietary information “Only.” The Government will not be responsible for proprietary, or competition sensitive information contained in responses received.
Responses to this announcement will not be returned. Responders are solely responsible for all expenses associated with responding to this announcement. Government will not be financially responsible for information received in response to this announcement. Phone calls will not be accepted.
The points of contact for this action are Kendall Spann, Contracts Specialist Email: Kendall.j.spann.ctr@health.mil or Faatalivale Te’o-Lewis, Contracting Officer; Email: Faatalivale.m.teo-lewis.civ@health.mil. Claudia Febres-Mormontoy will serve as a secondary POC: claudia.a.febresmormontoy.ctr@health.mil
Files
| File | Type | Posted |
|---|---|---|
| List of products.xlsx | XLSX spreadsheet |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside | |
| Brincidofovir oral SU | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6515--pyxis IV prep | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity